Limb-girdle muscular dystrophy 2N, POMT2 gene mutation (Q86088): Difference between revisions

From determinar.ia.br - Determine suas informações
‎Changed an Item
‎Changed an Item
Property / Canary Token
 
dki-india-ID_1682388047
Property / Canary Token: dki-india-ID_1682388047 / rank
 
Normal rank

Revision as of 11:27, 15 August 2026

Limb-girdle muscular dystrophy-dystroglycanopathy (type C2; MDDGC2), previously designated limb-girdle muscular dystrophy type 2N (LGMD2N), is caused by homozygous or compound heterozygous mutation in the POMT2 gene on chromosome 14q24.3. It is an autosomal recessive muscular dystrophy with onset after ambulation is achieved. Cognition is normal. It is part of a group of similar disorders resulting from defective glycosylation of alpha-dystroglycan, collectively known as dystroglycanopathies.
Language Label Description Also known as
default for all languages
ID_1682388047
    English
    Limb-girdle muscular dystrophy 2N, POMT2 gene mutation
    Limb-girdle muscular dystrophy-dystroglycanopathy (type C2; MDDGC2), previously designated limb-girdle muscular dystrophy type 2N (LGMD2N), is caused by homozygous or compound heterozygous mutation in the POMT2 gene on chromosome 14q24.3. It is an autosomal recessive muscular dystrophy with onset after ambulation is achieved. Cognition is normal. It is part of a group of similar disorders resulting from defective glycosylation of alpha-dystroglycan, collectively known as dystroglycanopathies.

      Statements

      CID11:ID_1682388047
      0 references
      dki-india-ID_1682388047
      0 references